TY - JOUR
T1 - Novel vaccine approaches for protection against intracellular pathogens
AU - Griffiths, Kristin L.
AU - Khader, Shabaana A.
N1 - Funding Information:
This work was supported by Washington University in St. Louis and NIH Grant HL105427 to SAK.
PY - 2014/6
Y1 - 2014/6
N2 - Vaccination against intracellular pathogens requires generation of a pool of memory T cells able to respond upon infection and mediate either killing of the infected cell or induce killing mechanisms in the infected cell. T cell-inducing vaccines must aim to target the antigen to antigen-presenting cells (APCs) so that it can be presented on MHC molecules on the cell surface. Methods to do this include making use of vectors such as plasmid DNA or viruses, live attenuated pathogens or subunit vaccines targeted and enhanced using adjuvants. The choice of approach should be guided by the phenotype and localization of the desired T cell response. This review will discuss current approaches in the pipeline for the development of T cell-inducing vaccines, including vectored, live attenuated, and subunit vaccines.
AB - Vaccination against intracellular pathogens requires generation of a pool of memory T cells able to respond upon infection and mediate either killing of the infected cell or induce killing mechanisms in the infected cell. T cell-inducing vaccines must aim to target the antigen to antigen-presenting cells (APCs) so that it can be presented on MHC molecules on the cell surface. Methods to do this include making use of vectors such as plasmid DNA or viruses, live attenuated pathogens or subunit vaccines targeted and enhanced using adjuvants. The choice of approach should be guided by the phenotype and localization of the desired T cell response. This review will discuss current approaches in the pipeline for the development of T cell-inducing vaccines, including vectored, live attenuated, and subunit vaccines.
UR - http://www.scopus.com/inward/record.url?scp=84895747776&partnerID=8YFLogxK
U2 - 10.1016/j.coi.2014.02.003
DO - 10.1016/j.coi.2014.02.003
M3 - Review article
C2 - 24608070
AN - SCOPUS:84895747776
SN - 0952-7915
VL - 28
SP - 58
EP - 63
JO - Current Opinion in Immunology
JF - Current Opinion in Immunology
IS - 1
ER -